Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Operating Income
88,330.00
75,579.00
67,493.00
65,381.00
69,044.00
63,245.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
88,330.00
75,579.00
67,493.00
65,381.00
69,044.00
63,245.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Operating Expenses
21.00
18.00
20.00
23.00
23.00
23.00
General and Administration Expenses
38,291.00
20,790.00
20,304.00
19,923.00
19,607.00
21,133.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
82,556.00
71,419.00
68,487.00
66,646.00
67,389.00
61,225.00
Operating Profit (PBDIT) excl Other Income
5,774.00
4,160.00
-994.00
-1,265.00
1,655.00
2,020.00
Other Income
13,064.00
10,143.00
14,777.00
18,373.00
5,347.00
3,599.00
Operating Profit (PBDIT)
23,453.00
18,414.00
17,743.00
20,701.00
10,001.00
8,018.00
Interest
21.00
18.00
20.00
23.00
23.00
23.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
4,615.00
4,254.00
4,109.00
3,730.00
3,148.00
2,562.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
15,610.00
14,449.00
13,680.00
16,507.00
7,476.00
4,630.00
Provision for Tax
3,634.00
3,159.00
3,046.00
3,475.00
2,098.00
1,741.00
Profit After Tax
11,961.00
11,161.00
10,529.00
12,922.00
5,285.00
2,817.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
274.20
246.58
228.30
280.19
113.25
60.30
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 16.87% vs 11.98% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 38.80% vs 518.51% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 16.67% vs -10.00% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 7.17% vs 6.00% in Mar 2024
Compare Profit and Loss Results of Kissei Pharmaceutical Co., Ltd.
Figures in Million
consolidated - Profit And Loss Results
Change(JPY)
Change(%)
No of Months
12
12
Operating Income
88,330.00
47,618.00
40,712.00
85.50%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
88,330.00
47,618.00
40,712.00
85.50%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
0.00
0.00
0%
Operating Expenses
21.00
478.00
-457.00
-95.61%
General and Administration Expenses
38,291.00
28,856.00
9,435.00
32.70%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
82,556.00
47,316.00
35,240.00
74.48%
Operating Profit (PBDIT) excl Other Income
5,774.00
302.00
5,472.00
1,811.92%
Other Income
13,064.00
989.00
12,075.00
1,220.93%
Operating Profit (PBDIT)
23,453.00
4,889.00
18,564.00
379.71%
Interest
21.00
478.00
-457.00
-95.61%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
4,615.00
3,598.00
1,017.00
28.27%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
15,610.00
-305.00
15,915.00
5,218.03%
Provision for Tax
3,634.00
-71.00
3,705.00
5,218.31%
Profit After Tax
11,961.00
-650.00
12,611.00
1,940.15%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
274.1973
-4.8393
279.04
5,766.05%
Profit And Loss - Net Sales
Net Sales 88,330.00 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 16.87% vs 11.98% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5,774.00 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 38.80% vs 518.51% in Mar 2024
Profit And Loss - Interest
Interest 21.00 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 16.67% vs -10.00% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 11,961.00 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 7.17% vs 6.00% in Mar 2024






